Engrail Therapeutics closed an oversubscribed $157M Series B financing round co-led by F-Prime Capital, Forbion, and Norwest Venture Partners to advance the development of transformational therapies.
Amount Raised
$157 Million
Round Type
Series B
San DiegoBiotechnologyHealth CareTherapeuticsInvestors
Description
Engrail Therapeutics announced the close of an oversubscribed $157 million Series B financing round, co-led by new investors F-Prime Capital, Forbion, and Norwest Venture Partners, with participation from several other investors. The funding will be used to propel the advancement of the Company’s pipeline through multiple stages of clinical development, focusing on diseases with significant unmet medical need.
Quick answer
Engrail Therapeutics raised $157 Million in a Series B round, dated March 19, 2024. Investors: Pivotal Life Sciences, Eight Roads Ventures, Longwood Fund, Ysios Capital, Abrdn Inc., Red Tree Venture Capital, River Vest Venture Partners and Norwest Venture Partners. Engrail Therapeutics is based in San Diego, California, United States.
- How much did Engrail Therapeutics raise?
- Engrail Therapeutics raised $157 Million in a Series B round on March 19, 2024.
- Who invested in Engrail Therapeutics?
- Pivotal Life Sciences, Eight Roads Ventures, Longwood Fund, Ysios Capital, Abrdn Inc., Red Tree Venture Capital, River Vest Venture Partners and Norwest Venture Partners are named as investors in this round.
- What does Engrail Therapeutics do?
- Engrail Therapeutics is a precision neuroscience company focused on developing transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental diseases.
- Where is Engrail Therapeutics based and how big is it?
- Engrail Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Engrail Therapeutics?
- Fundz holds 1 contact at Engrail Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Engrail Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- BridgeBio raised $200M (Pre-Seed) on May 3, 2024.
- Zenas BioPharma raised $200M on May 3, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
Who to call at Engrail Therapeutics, and when
A new round usually means Engrail Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Engrail Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Engrail Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Engrail Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Engrail Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEngrail Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.